L Zheng, H Teschler, J Guzman, K Hubner, I Striz and U Costabel
Department of Pneumology and Allergy, Ruhrlandklinik, Medical Faculty, University of Essen, Germany.

The aim of this study was to investigate the relationship between release of tumor necrosis factor-alpha (TNF-alpha) by alveolar macrophages (AM) and the phenotypic characteristics of bronchoalveolar lavage (BAL) cells in sarcoidosis. We studied the spontaneous release of TNF-alpha by AM in vitro and the phenotypic characteristics of freshly recovered BAL T-cells and AM in 31 individuals (13 with active sarcoidosis, nine with inactive sarcoidosis, and nine normal controls). TNF-alpha was measured by enzyme-linked immunosorbent assay (ELISA) in supernatants from unstimulated AM after 24 h culture. Phenotypic markers of BAL cells were determined by an immunocytochemical assay. AM of patients with active sarcoidosis released more TNF-alpha (1,355 +/- 133 pg/ml/ 10(6) AM/24 h) than those of the inactive group (651 +/- 142 pg/ml/10(6) AM/24 h) or the normal controls (425 +/- 121 pg/ml/10(6) AM/24 h), with p < 0.001 for both comparisons. The amount of TNF-alpha released correlated positively with the percentage expression of CD4 (r = 0.72) and CD25 (r = 0.70) by lymphocytes, and of CD14 (r = 0.63), VLA- 4 (r = 0.59), FRD1 (r = 0.67) and 27E10 (r = 0.67) by AM, with p < 0.001 for all correlations. In conclusion, this relationship suggests that these antigens may be considered as cellular activation markers, and that some of these AM antigens may indirectly characterize the AM phenotype that is capable of producing TNF-alpha.

This article has been cited by other articles:

				F G Joseph and N J Scolding Sarcoidosis of the nervous system Practical Neurology, August 1, 2007; 7(4): 234 - 244. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi and B. A. Rybicki Genetics of Sarcoidosis: Candidate Genes and Genome Scans Proceedings of the ATS, January 1, 2007; 4(1): 108 - 116. [Abstract] [Full Text] [PDF]

				J. D. Doty, J. E. Mazur, and M. A. Judson Treatment of Sarcoidosis With Infliximab Chest, March 1, 2005; 127(3): 1064 - 1071. [Abstract] [Full Text] [PDF]

				H. Dai, J. Guzman, B. Chen, and U. Costabel Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-{alpha} by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis Chest, January 1, 2005; 127(1): 251 - 256. [Abstract] [Full Text] [PDF]

				C Pritchard and K Nadarajah Tumour necrosis factor {alpha} inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients Ann Rheum Dis, March 1, 2004; 63(3): 318 - 320. [Abstract] [Full Text] [PDF]

				Z. Tong, H. Dai, B. Chen, Z. Abdoh, J. Guzman, and U. Costabel Inhibition of Cytokine Release From Alveolar Macrophages in Pulmonary Sarcoidosis by Pentoxifylline: Comparison With Dexamethasone Chest, October 1, 2003; 124(4): 1526 - 1532. [Abstract] [Full Text] [PDF]

				S. Rothkrantz-Kos, M. P. van Dieijen-Visser, P. G.H. Mulder, and M. Drent Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis Clin. Chem., September 1, 2003; 49(9): 1510 - 1517. [Abstract] [Full Text] [PDF]

				J. C. Grutters, H. Sato, P. Pantelidis, A. L. Lagan, D. S. McGrath, J.-W. J. Lammers, J. M. M. van den Bosch, A. U. Wells, R. M. du Bois, and K. I. Welsh Increased Frequency of the Uncommon Tumor Necrosis Factor -857T Allele in British and Dutch Patients with Sarcoidosis Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1119 - 1124. [Abstract] [Full Text] [PDF]

				O. P. Sharma Tumor Necrosis Factor Polymorphism in Sarcoidosis Chest, March 1, 2001; 119(3): 678 - 679. [Full Text] [PDF]

				S. Rosseau, P. Hammerl, U. Maus, H.-D. Walmrath, H. Schutte, F. Grimminger, W. Seeger, and J. Lohmeyer Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L25 - L35. [Abstract] [Full Text] [PDF]

				L. J. MARQUES, L. ZHENG, N. POULAKIS, J. GUZMAN, and U. COSTABEL Pentoxifylline Inhibits TNF-alpha Production from Human Alveolar Macrophages Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 508 - 511. [Abstract] [Full Text]